Chemical Compound

Erlotinib

CAS Registry Number 183321-74-6
Erlotinib chemical structure
Primary Record

Erlotinib

In stock
5,251 g
Purity
99.3 %
CAS
183321-74-6

Compound Identifiers & Properties

CAS
183321-74-6
PubChem CID
176870
SMILES
COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
Canonical SMILES
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1

Names & Synonyms

  • Erlotinib
  • Tarceva
  • 183321-74-6
  • Erlotinib Base
  • erlotinibum
  • Erlotinib free base
  • Erlotinib hydrochloride
  • Erlotinib [INN]
  • Erlotinin
  • Erotinib
  • erlotinib;
  • erlotinib HCl
  • Erlotinib(Tarceva)
  • Erlotinib (INN)
  • Erlotinib, Free Base
  • N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
  • Tarceva (TN)
  • nchembio866-comp3
  • Erlotinib, OS-774
  • Erlotinib [INN:BAN]
  • Erlotinib free base?
  • Erlotinib (Standard)
  • J4T82NDH7E
  • RefChem:5799
  • Kinome_3317
  • OSI-774
  • CHEMBL553
  • UNII-J4T82NDH7E
  • ERLOTINIB [MI]
  • MFCD02089651
  • ERLOTINIB [VANDF]
  • DTXSID8046454
  • D07POC
  • Erlotinib hydrochloride CRS
  • AC1L42EI
  • ERLOTINIB [WHO-DD]
  • SCHEMBL8413
  • C22H23N3O4
  • DTXCID6026454
  • ERLOTINIB [EMA EPAR]
  • Erlotinib HCL Intermediate 3
  • HSDB 8082
  • CHEBI:114785
  • OSI 744
  • 183321-74-6 (free base)
  • BDBM5446
  • cid_176870
  • GTPL4920
  • orb1310678
  • QUI124
  • Erlotinib, 98% - 1G 1g
  • Tyrosine Kinase Inhibitor - Ns
  • 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
  • Erlotinib Hydrochloride -Form A
  • NSC 718781
  • SCHEMBL29351329
  • SCHEMBL30362833
  • 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline
  • RG-1415
  • CP-358774
  • L01XE03
  • OSI-744
  • QCR-100
  • AAKJLRGGTJKAMG-UHFFFAOYSA-N
  • s7786
  • 2-Boc-amino-4-bromomethylpyridine
  • HMS2089F05
  • HMS3244M19
  • HMS3244M20
  • HMS3244N19
  • HMS3295A19
  • HMS3713C22
  • HMS3745M05
  • HMS5085P20
  • N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
  • AMX10161
  • MSK10717
  • ZINC1546066
  • Tox21_112202
  • 3615AH
  • AC-399
  • CID176870
  • EBC-00690
  • FC0029
  • HY-50896R
  • NCGC00164574-01
  • NSC718781
  • NSC800097
  • R-1415
  • STK623143
  • CP-358,774
  • CP358774
  • AKOS000282911
  • C22-H23-N3-O4
  • CP-35877401
  • Tox21_112202_1
  • ACN-036244
  • CCG-220420
  • CS-0620
  • CS-O-31362
  • DB00530
  • NSC-718781
  • NSC-800097
  • RL02337
  • Ro-508231
  • SB16916
  • SDCCGSBI-0634409.P005
  • NCGC00164574-03
  • NCGC00164574-05
  • NCGC00164574-06
  • NCGC00164574-14
  • NCGC00164574-25
  • AJ-26877
  • AK142763
  • AN-15876
  • AS-35132
  • BC215797
  • BCB03_000783
  • BE164419
  • BP-43654
  • CJ-05292
  • EN002711
  • HY-50896
  • P443
  • SY028059
  • R 1415
  • AB0017012
  • AB1004620
  • J910.423B
  • LS-184395
  • 2159B
  • A3397
  • AM20090621
  • CAS-183321-74-6
  • CP 358,774
  • FT-0651539
  • NS00006169
  • ST24046689
  • KS-00000642
  • [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE
  • A11416
  • D07907
  • EN300-708808
  • K00241
  • S-7717
  • 15214-EP2269994A1
  • 15214-EP2272827A1
  • 15214-EP2281815A1
  • 15214-EP2292234A1
  • 15214-EP2292615A1
  • 15214-EP2295432A1
  • 15214-EP2298778A1
  • 15214-EP2301533A1
  • 15214-EP2301933A1
  • 15214-EP2305640A2
  • 15214-EP2305671A1
  • 15214-EP2305687A1
  • 15214-EP2308855A1
  • 15214-EP2311827A1
  • 15214-EP2311840A1
  • 15214-EP2311842A2
  • 15214-EP2316832A1
  • 15214-EP2316833A1
  • 32334-EP2281815A1
  • 32334-EP2292615A1
  • 32334-EP2301933A1
  • 32334-EP2305640A2
  • 32334-EP2305671A1
  • 32334-EP2311827A1
  • AB01273955-01
  • AB01273955-02
  • AB01273955-03
  • CP-358,774-01
  • 134172-EP2292233A2
  • 321E746
  • A812764
  • F050702
  • Q418369
  • SR-05000001460
  • 183319-69-9
  • I01-1241
  • SR-05000001460-1
  • SR-05000001460-2
  • SR-05000001460-3
  • SR-05000001460-6
  • [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine
  • BRD-K70401845-001-15-7
  • BRD-K70401845-003-04-7
  • BRD-K70401845-003-09-6
  • Z2588038919
  • 4-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)quinazoline
  • AQ4
  • 4-(3-Ethynylphenylamino)-6,7-bis(3-oxabutane-1-yloxy)quinazoline
  • 4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-
  • n-(3-ethynylphenyl)(6,7-bis(2-methoxyethoxy)quinazolin-4-yl)amine
  • n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazoline-4-amine
  • n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine
  • (6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl)-(3-ethynyl-phenyl)-amine
  • 1429636-49-6
  • Erlortinib; 4-[(3-Ethynylphenyl)Amino]-6,7-Bis(2-Methoxyethoxy)Quinazoline
  • 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)
  • n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride
  • 4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-Quinazolinamine; Erlotinin; Erlotinib Base
  • Erlotinib; 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; NSC 718781; OSI 744; R 1415